OBI-858
- Generic Name
- OBI-858
Effect of Different Treatment Techniques on Masseter Muscle Thickness
Not Applicable
Completed
- Conditions
- BruxismMasseter Muscle Hypertrophy
- Interventions
- First Posted Date
- 2024-09-13
- Last Posted Date
- 2024-09-13
- Lead Sponsor
- Zonguldak Bulent Ecevit University
- Target Recruit Count
- 48
- Registration Number
- NCT06593821
- Locations
- 🇹🇷
Zonguldak Bülent Ecevit University, Zonguldak, Kozlu, Turkey
Effectiveness of Botox, Dry Needling, Pharmacological Treatment, and Manual Therapy for Bruxism-Induced Myalgia
Not Applicable
Completed
- Conditions
- MyalgiaBruxismQuality of Life
- Interventions
- First Posted Date
- 2024-09-04
- Last Posted Date
- 2024-09-04
- Lead Sponsor
- Saglik Bilimleri Universitesi
- Target Recruit Count
- 80
- Registration Number
- NCT06583551
- Locations
- 🇹🇷
University of Health Sciences, Istanbul, Turkey
Strategy to Adapt Botulinum Toxin Doses in Dystonia
Not yet recruiting
- Conditions
- Dystonia
- First Posted Date
- 2024-04-26
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- Central Hospital, Nancy, France
- Target Recruit Count
- 100
- Registration Number
- NCT06386848
Effect of Topical Botulinum Toxin Eyedrop on Palpebral Fissure
- First Posted Date
- 2023-10-12
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 2
- Registration Number
- NCT06080438
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis
Phase 3
Recruiting
- Conditions
- Carpometacarpal SprainThumb SprainClostridium; Botulinum
- Interventions
- Drug: Standard-of-care corticosteroid injections
- First Posted Date
- 2023-08-14
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Rhode Island Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05990881
- Locations
- 🇺🇸
235 Plain Street, Providence, Rhode Island, United States
Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization
Phase 2
Active, not recruiting
- Conditions
- ScarHypertrophic Scar
- Interventions
- Drug: Normal saline
- First Posted Date
- 2022-07-28
- Last Posted Date
- 2024-04-04
- Lead Sponsor
- Henry Ford Health System
- Target Recruit Count
- 12
- Registration Number
- NCT05478551
- Locations
- 🇺🇸
Henry Ford Health System, Detroit, Michigan, United States
Botulinum Toxin Therapy in Hidradenitis Suppurativa
- First Posted Date
- 2022-06-03
- Last Posted Date
- 2024-06-12
- Lead Sponsor
- University of Massachusetts, Worcester
- Target Recruit Count
- 20
- Registration Number
- NCT05403710
- Locations
- 🇺🇸
University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States
Botulinum Toxin in Raynaud's Phenomenon
- First Posted Date
- 2021-11-18
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Emory University
- Target Recruit Count
- 36
- Registration Number
- NCT05125029
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
Effect of Botulinum Toxin on Hamstring Contracture and the Occurrence of Cyclops Syndrome After Anterior Cruciate Ligament Reconstruction
Phase 3
Not yet recruiting
- Conditions
- Hamstring Contractures
- Interventions
- Other: Placebo
- First Posted Date
- 2021-08-17
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche
- Target Recruit Count
- 132
- Registration Number
- NCT05008731
- Locations
- 🇫🇷
Clinique du Sport, Paris, France
Assessment of Pain After Intra-articular Botulinum Toxin Injections in Carpometacarpal Osteoarthritis of the Thumb
- First Posted Date
- 2021-04-02
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Centre Hospitalier Universitaire de Nice
- Target Recruit Count
- 60
- Registration Number
- NCT04829565
- Locations
- 🇫🇷
CHU de Nice, Nice, Paca, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath